Helix Biopharma Corp
TSX:HBP

Watchlist Manager
Helix Biopharma Corp Logo
Helix Biopharma Corp
TSX:HBP
Watchlist
Price: 2.18 CAD 3.32% Market Closed
Market Cap: 166.5m CAD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of HBP.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HBP Intrinsic Value
Not Available
Base Case Scenario
Compare HBP to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HBP?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Helix Biopharma Corp

Current Assets 409k
Cash & Short-Term Investments 65k
Receivables 121k
Other Current Assets 223k
Non-Current Assets 18.4m
PP&E 4k
Intangibles 18.4m
Current Liabilities 3.2m
Accounts Payable 2.3m
Accrued Liabilities 578k
Short-Term Debt 335k
Efficiency

Free Cash Flow Analysis
Helix Biopharma Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Helix Biopharma Corp

Revenue
0 CAD
Operating Expenses
-5.4m CAD
Operating Income
-5.4m CAD
Other Expenses
192k CAD
Net Income
-5.2m CAD
Fundamental Scores

HBP Profitability Score
Profitability Due Diligence

Helix Biopharma Corp's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional 3Y Average ROE
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
49/100
Profitability
Score

Helix Biopharma Corp's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

HBP Solvency Score
Solvency Due Diligence

Helix Biopharma Corp's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Positive Net Debt
Short-Term Solvency
43/100
Solvency
Score

Helix Biopharma Corp's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HBP Price Targets Summary
Helix Biopharma Corp

There are no price targets for HBP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Helix Biopharma Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for HBP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y